SAT344 - No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland. - Olafsson, Sigurdur; Löve, Thorvardur J.; Fridriksdottir, Ragnheidur H.; Tyrfingsson, Thorarinn; Runarsdottir, Valgerdur; Hansdottir, Ingunn; Bergmann, Ottar M.; Björnsson, Einar S.; Johannsson, Birgir; Sigurdardottir, Bryndis; Löve, Arthur; Baldvinsdóttir, Guðrún Erna; et al. (Journal of Hepatology, 2020)